In the crowded cardio space, it’s David vs. Goliath for small biotechs

[cafead]

via The cardiovascular space is filled with some of the biggest pharma and biotech players in the world. Not only did the weight loss phenomenon Wegovy score a cardiovascular indication last year, but giants like Merck & Co. are making moves, too.

article source